Annual Report and Accounts

RNS Number : 4567C

Allergy Therapeutics PLC

16 October 2015

 



16 October 2015

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Annual Report and Accounts

Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that the Annual Report and Accounts for the year ended 30 June 2015 are available on the Company's website in the Investor Relations section. They can be located at:

www.allergytherapeutics.com/media/1216/atl-financial-statements-june-2015.pdf 

Printed copies of the Annual Report and Accounts for the year end 30 June 2015 will be posted to shareholders together with the Notice of the Annual General Meeting on 20 October 2015.

For further information:

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
Panmure Gordon	[phone]
Freddy Crossley / Peter Steel / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
FTI Consulting	[phone]
Simon Conway
Victoria Foster Mitchell

Note to editors:

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination.  It has a growing business achieving revenue in the last financial year of £43 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.

 

END

 

 

ACSBRBDGLSBBGUU